ExploreWatchlistsPricing
  1. JP-listed companies
  2. MIZUHO MEDY CO.,LTD.
  3. Financials
  4. Net income

MIZUHO MEDY CO.,LTD. (4595)

Market cap
¥35.1B
P/E ratio
10.9x
Mizuho Medic develops and manufactures diagnostic test kits for hospitals and consumers, specializing in infectious disease testing including COVID-19 and influenza.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndNet income (Million JPY)YoY (%)
Dec 31, 20253,425-9.22%
Dec 31, 20243,773-0.03%
Dec 31, 20233,774-51.85%
Dec 31, 20227,838+62.73%
Dec 31, 20214,817+1472.33%
Dec 31, 2020306-64.96%
Dec 31, 2019874-4.88%
Dec 31, 2018919+39.26%
Dec 31, 2017660+67.01%
Dec 31, 2016395+53.42%
Dec 31, 2015258-18.81%
Dec 31, 2014317+128.06%
Dec 31, 2013139+61.15%
Dec 31, 201286+740.23%
Dec 31, 201110

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat